A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Female Subjects
Clinical trial NCT02788721 · COMPLETED
Trial details
- NCT number
- NCT02788721
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-14
- Primary completion
- 2017-04-27
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.